Usefulness of longitudinal evaluation of Cyfra 21-1 variations in advanced lung cancer monitoring

This publication has 14 references indexed in Scilit:

• Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer
  Lung Cancer, 1996
• Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status
  Lung Cancer, 1995
• Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer
  European Respiratory Journal, 1995
• Simple cytokeratins in the serum of patients with lung cancer: Relationship to cell death
  European Journal Of Cancer, 1994
• CYFRA 21-1 as a biological marker of lung cancer. Evaluation of sensitivity, specificity and prognostic role
  Lung Cancer, 1994
• Serum tumour markers in lung cancer: history, biology and clinical applications
  European Respiratory Journal, 1994
• CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation
  European Journal Of Cancer, 1994
• CYFRA 21-1: A new marker in lung cancer
  Cancer, 1993
• Neuron-specific enolase (NSE) in small-cell lung cancer: longitudinal tumor marker evaluation
  Lung Cancer, 1992
• Predictive value of laboratory tests
  The American Journal of Cardiology, 1975